Complete Revascularization Associated with Significant Improvement in LVEF and Long-term Survival In this video, Dr. Amin Medjamia interviews Francesco Burzotta, MD and Carlo Trani, MD, from the Institute of Cardiology, Catholic University of the Sacred Heart in Rome. The cardiologists discuss their most recent manuscript, Long-Term Outcomes of Extent of Revascularization in Complex High Risk … Continue reading “Roma Verona Impella ProPCI Study Summary with Dr. Burzotta and Dr. Trani”
Tag: complete revascularization
- This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
- Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
- In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
- The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Dr. Marty Leon outlines the important role of hemodynamic support for complete revascularization in CHIP patients. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI ICP-075-16
Dr. Ehrin Armstrong, Director, Interventional Cardiology at University of Colorado VA – Denver Veteran’s Administration Hospital, shares a Protected PCI case of a 92-year-old veteran of WWII who was revascularized and is now back to his daily activities, with Dr. Cathy Jeon. ProtectedPCI.com celebrates and thanks all U.S. veterans for their service. Tweet this, join … Continue reading “92 Year Old WWII Veteran Benefits from Protected PCI with Impella®”
Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses
Dr. Jeffrey Moses, Director of Interventional Cardiac Therapeutics at Columbia University Medical Center, NY and Director of Complex Coronary Interventions at St. Francis Hospital, has been a pioneer in developing the techniques and data to optimize complex PCI. At this year’s Hartzler Interventional Cardiology Symposium, Dr. Moses presents a strong case for why complete revascularization … Continue reading “Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses”
Tulane University School of Medicine’s Dr. Nidal Abi Rafeh shares a fascinating case of complete revascularization using Protected PCI and Impella. The case is also an example of the need for cardiologists and interventional cardiologist, in particular, to constantly develop skill sets. Tweet this or subscribe to be alerted of future case reviews.
Heart Team Recommends Protected PCI vs. Medical Management for Treatment of 3VD After Surgical Turn Down
Today’s case review comes from the University of Washington’s Dr. Ravi Hira, who presents a ProtectedPCI case involving three-vessel intervention. Dr. Hira is Assistant Professor and Director of the Acute Cardiac Catheterization Service at Harborview Medical Center. His case involves the complete revascularization of a patient, who was successfully released from the hospital in relatively … Continue reading “Heart Team Recommends Protected PCI vs. Medical Management for Treatment of 3VD After Surgical Turn Down”
Data is emerging to support the notion that leaving patients behind with un-revascularized territories may be a risk to be discussed with patients. The key challenge is to completely revascularize patients. Dr. George Vetrovec, Professor Emeritus of the Virginia Commonwealth University, shares his thoughts with ProtectedPCI.com’s Dr. Seth Bilazarian in the podcast below covering completeness … Continue reading “Dr. George W. Vetrovec Discusses Completeness of Revascularization”